5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.76▲ | 0.76▼ | 0.76▼ | 0.71▲ | 0.70▲ |
MA10 | 0.76▼ | 0.75▲ | 0.73▲ | 0.68▲ | 0.50▲ |
MA20 | 0.74▲ | 0.73▲ | 0.72▲ | 0.70▲ | 0.43▲ |
MA50 | 0.72▲ | 0.70▲ | 0.68▲ | 0.49▲ | 0.51▲ |
MA100 | 0.69▲ | 0.70▲ | 0.72▲ | 0.43▲ | 1.10▼ |
MA200 | 0.67▲ | 0.70▲ | 0.62▲ | 0.50▲ | 2.14▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.003▲ | 0.005▲ | -0.012▼ | 0.068▲ |
RSI | 55.450▲ | 55.873▲ | 59.866▲ | 59.981▲ | 60.621▲ |
STOCH | 68.926 | 62.267 | 64.501 | 49.242 | 60.466 |
WILL %R | -14.690▲ | -33.066 | -33.066 | -36.745 | -34.915 |
CCI | 42.677 | 54.917 | 75.021 | 51.099 | 104.008▲ |
Friday, August 08, 2025 12:37 AM
Key Points GAAP EPS was $(0.11) for Q2 2025, missing estimates by $(0.005) per share. GAAP grant income, reported as revenue, reached $7.1 million for Q2 2025, far ahead of analysts' expectation of $0 ...
|
Thursday, August 07, 2025 01:14 PM
Discussed plans to support a pivotal Alzheimer’s disease program with FDA at end-of-phase 2 meeting - - Initiated expanded access program (EAP) for people with dementia with Lewy bodies (DLB) - - ...
|
Tuesday, July 29, 2025 04:49 AM
Zervimesine’s impact on debilitating DLB behavioral symptoms highlighted in podium presentation -- Plasma p-tau217 levels can identify Alzheimer’s patients most likely to benefit from zervimesine ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 0.6755 | 0.855 | 0.6755 | 0.7545 | 3,589,968 |
07/08/25 | 0.71 | 0.7233 | 0.6012 | 0.677 | 1,743,030 |
06/08/25 | 0.70 | 0.7221 | 0.677 | 0.711 | 971,257 |
05/08/25 | 0.7137 | 0.74 | 0.7101 | 0.716 | 1,237,138 |
04/08/25 | 0.6933 | 0.7278 | 0.6729 | 0.7138 | 1,684,230 |
01/08/25 | 0.5555 | 0.6996 | 0.5555 | 0.6674 | 4,092,719 |
31/07/25 | 0.6088 | 0.6247 | 0.5661 | 0.5858 | 2,291,805 |
30/07/25 | 0.6701 | 0.6793 | 0.6008 | 0.6222 | 2,482,412 |
29/07/25 | 0.75 | 0.75 | 0.63 | 0.6702 | 8,057,575 |
28/07/25 | 0.84 | 0.8499 | 0.6188 | 0.7151 | 6,875,779 |
|
|
||||
|
|
||||
|
|